In addition to the bright sun being so prevalent during these warm summer months, the fraud and abuse enforcement spotlight shines bright on Oklahoma and Florida.
In Oklahoma, two cases were filed involving a total of three physicians and five marketers, who were all charged with anti-kickback violations involving compounded prescription drugs. In one case, the fallout continues from the compounding pharmacy prescription scheme involving OK Compounding where three physicians and a marketer were charged with anti-kickback violations and other criminal offenses. The allegations involved kickback payments disguised through medical director and consulting arrangements with the pharmacies. In a second case, a Texas marketer was charged with conspiracy to pay health care kickbacks for recruiting physicians to prescribe compounded drugs in exchange for a commission based upon reimbursed prescriptions. In the final case, three marketers were charged with kickback violations for a direct payment to a prescribing physician.
These cases offer a reminder that medical director, consulting, and marketing arrangements are heavily scrutinized and will not disguise any intent to pay for referrals. Parties must carefully analyze their arrangements and ensure the intent and substance behind the arrangement matches the form of the contract.
In Florida, an owner of a substance abuse facility pled guilty in a massive $57M money laundry conspiracy involving hospital pass-through billing. In the scheme, the owner arranged for his facility to send patient urine samples to a laboratory for testing in exchange for 40% of the insurance reimbursement. The laboratory in turn entered into arrangements with rural hospitals to have the testing billed under the hospital’s provider number using hospital in-network contracts. The owner also arranged for other substance abuse facilities to participate and receive 30% of the insurance reimbursement while he received the other 10%.
Hospital pass-through billing arrangements have become problematic as hospitals, clinical laboratories, and other parties seek arrangements to maximize both operations and profits. Arrangements between hospitals and laboratories must be closely scrutinized and regulatory compliance carefully analyzed.
If you have any health care compliance questions or concerns, please schedule a consult at firstname.lastname@example.org.